NIH-funded research R21 grant

Developing new methods for incorporating fluorine-18 into complex molecules for imaging

Official title: Metal Fluorination For biomolecules: Expanding The Radiofluorination Toolbox

Funded at Johns Hopkins University · NIH-11057029 · Data updated 2026-11-12

This study is working on new ways to make better imaging tools for diagnosing cancer, especially by improving how we use a special chemical called fluorine-18 in complex molecules, which could help doctors see and treat conditions like prostate cancer more effectively.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startDecember 5, 2024
Project endNovember 30, 2027
Funding year2025
Award (this year)$174,375
NIH project number1R21EB035675-01A1
Project IDNIH-11057029 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing evaluation for prostate cancer or other conditions where advanced imaging techniques are beneficial.

Less likely to help

Patients who do not have conditions requiring advanced molecular imaging or those who are not candidates for imaging studies may not benefit from this research.

What this research studies

This research focuses on improving molecular imaging techniques by developing innovative methods for incorporating fluorine-18 into complex biomolecules. The approach involves creating irreversible metal-fluorine bonds, which could enhance the effectiveness of existing fluorination methods. By evaluating different metal centers for their pharmacological properties, the research aims to create more efficient imaging agents that can also be paired with therapeutic isotopes. This could lead to better diagnostic tools for conditions like cancer, particularly targeting prostate-specific membrane antigen (PSMA) and carbonic anhydrase IX (CAIX).

Why it matters

Potential benefit: If successful, this research could lead to more effective imaging techniques that improve the diagnosis and treatment of various cancers.

How similar studies have gone: Previous research has shown promise in enhancing imaging techniques through novel radiochemistry approaches, indicating potential for success in this area.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Carroll, Laurence — Johns Hopkins University
  • Study coordinator: Carroll, Laurence

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.